Sangamo BioSciences Inc. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
101.67 M |
Public Float |
87.1 M |
Sangamo BioSciences Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$0.89 |
Market Cap |
$1.17 B |
Shares Outstanding |
115.36 M |
Public Float |
101.84 M |
Address |
Point Richmond Tech Center II Richmond California 94804 United States |
Employees | - |
Website | http://www.sangamo.com |
Updated | 07/08/2019 |
Sangamo Therapeutics, Inc. researches and develops transcription factors in the regulation of genes. It focuses on the research, development and commercialization of engineered DNA-binding proteins for therapeutic genome editing and gene regulation technology platform is enabled by the engineering of a class of transcription factors known as zinc finger DNA-binding proteins. The company was founded by Edward O. |